Quest Diagnostics Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Quest Diagnostics stock has a consensus rating of "Buy" and an average price target of $223.44. The average 1-year stock price forecast is 10.04% higher than the current stock price, while the lowest is $184 (-9.39%) and the highest is $245 (+20.65%).

Price Target: $223.44 (+10.04%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$184	$223.44	$225	$245
Change	-9.39%	+10.04%	+10.80%	+20.65%

* Price targets were last updated on May 7, 2026.

Analyst Ratings

The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	7	7	7	7	7
Buy	2	2	2	2	2	2
Hold	8	8	9	9	9	9
Sell	1	1	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	18	18	18	18	18	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lisa Gill J.P. Morgan	J.P. Morgan	Hold Maintains $220	Hold	Maintains	$220	+8.34%	May 7, 2026
Kevin Caliendo UBS	UBS	Hold Maintains $210 → $220	Hold	Maintains	$210 → $220	+8.34%	Apr 22, 2026
David S Macdonald Truist Financial	Truist Financial	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Apr 22, 2026
Eric Coldwell Robert W. Baird	Robert W. Baird	Hold Maintains $224 → $229	Hold	Maintains	$224 → $229	+12.77%	Apr 22, 2026
Luke Sergott Barclays	Barclays	Buy Maintains $225 → $230	Buy	Maintains	$225 → $230	+13.27%	Apr 22, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

11.85B

from 11.04B

7.42%

from 11.04B

Revenue Next Year

12.38B

from 11.85B

4.42%

from 11.85B

EPS This Year

10.77

from 9.85

9.33%

from 9.85

EPS Next Year

11.67

from 10.77

8.37%

from 10.77

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	10.79B	9.88B	9.25B	9.87B	11.04B	11.85B
Revenue Growth	14.32%	-8.39%	-6.39%	6.70%	11.78%	7.42%
Gross Profit	4.22B	3.45B	3.07B	3.27B	3.68B	3.94B
Gross Margin	39.09%	34.93%	33.14%	33.15%	33.33%	33.22%
Operating Income	2.39B	1.50B	1.32B	1.41B	1.61B	1.89B
Net Income	2.00B	946.00M	854.00M	871.00M	992.00M	1.09B
EPS	-	-	-	-	9.85	10.77
EPS Growth	-	-	-	-	10.30%	9.33%
Forward PE	18.61	18.91	15.53	15.97	17.07	18.86
Dividend / Share	2.48	2.64	2.84	3.00	3.20	3.21
Dividend Growth	-	6.45%	7.58%	5.63%	6.67%	0.25%
Free Cash Flow	1.56B	1.02B	651.63M	743.50M	1.01B	1.45B
No. Analysts	-	-	-	-	-	16

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	11.9B
Avg	11.9B
Low	11.8B

Revenue Growth

Revenue Growth	2026	2027	2028
High	8.0%
Avg	7.4%
Low	6.8%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	10.77
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	9.3%
Low	-